The cost of treating severe refractory asthma in the UK: an economic analysis from the British Thoracic Society Difficult Asthma Registry.

Stephen O'Neill; Joan Sweeney; Chris C Patterson; Andrew Menzies-Gow; Rob Niven; Adel H Mansur; Christine Bucknall; Rekha Chaudhuri; Neil C Thomson; Chris E Brightling; Ciaran O'Neill; Liam G Heaney

doi:10.1136/thoraxjnl-2013-204114

The cost of treating severe refractory asthma in the UK: an economic analysis from the British Thoracic Society Difficult Asthma Registry.

Stephen O'Neill, Joan Sweeney, Chris C Patterson, Andrew Menzies-Gow, Rob Niven, Adel H Mansur, Christine Bucknall, Rekha Chaudhuri, Neil C Thomson, Chris E Brightling, Ciaran O'Neill, Liam G Heaney

Research output: Contribution to journal › Article › peer-review

Abstract

Severe refractory asthma poses a substantial burden in terms of healthcare costs but relatively little is known about the factors which drive these costs. This study uses data from the British Thoracic Society Difficult Asthma Registry (n=596) to estimate direct healthcare treatment costs from an National Health Service perspective and examines factors that explain variations in costs. Annual mean treatment costs among severe refractory asthma patients were £2912 (SD £2212) to £4217 (SD £2449). Significant predictors of costs were FEV1% predicted, location of care, maintenance oral corticosteroid treatment and body mass index. Treating individuals with severe refractory asthma presents a substantial cost to the health service.

Original language	English
Journal	Thorax
Volume	70
Issue number	4
DOIs	https://doi.org/10.1136/thoraxjnl-2013-204114
Publication status	Published - Apr 2015

Keywords

Asthma
Health Economist

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1136/thoraxjnl-2013-204114

Cite this

O'Neill, S., Sweeney, J., Patterson, C. C., Menzies-Gow, A., Niven, R., Mansur, A. H., Bucknall, C., Chaudhuri, R., Thomson, N. C., Brightling, C. E., O'Neill, C., & Heaney, L. G. (2015). The cost of treating severe refractory asthma in the UK: an economic analysis from the British Thoracic Society Difficult Asthma Registry. Thorax, 70(4). https://doi.org/10.1136/thoraxjnl-2013-204114

@article{6e8ef38f267d4c64bb3ef72972a65e45,

title = "The cost of treating severe refractory asthma in the UK: an economic analysis from the British Thoracic Society Difficult Asthma Registry.",

abstract = "Severe refractory asthma poses a substantial burden in terms of healthcare costs but relatively little is known about the factors which drive these costs. This study uses data from the British Thoracic Society Difficult Asthma Registry (n=596) to estimate direct healthcare treatment costs from an National Health Service perspective and examines factors that explain variations in costs. Annual mean treatment costs among severe refractory asthma patients were £2912 (SD £2212) to £4217 (SD £2449). Significant predictors of costs were FEV1% predicted, location of care, maintenance oral corticosteroid treatment and body mass index. Treating individuals with severe refractory asthma presents a substantial cost to the health service.",

keywords = "Asthma, Health Economist",

author = "Stephen O'Neill and Joan Sweeney and Patterson, {Chris C} and Andrew Menzies-Gow and Rob Niven and Mansur, {Adel H} and Christine Bucknall and Rekha Chaudhuri and Thomson, {Neil C} and Brightling, {Chris E} and Ciaran O'Neill and Heaney, {Liam G}",

note = ", Wellcome Trust, United Kingdom",

year = "2015",

month = apr,

doi = "10.1136/thoraxjnl-2013-204114",

language = "English",

volume = "70",

journal = "Thorax",

issn = "1468-3296",

publisher = "BMJ ",

number = "4",

}

O'Neill, S, Sweeney, J, Patterson, CC, Menzies-Gow, A, Niven, R, Mansur, AH, Bucknall, C, Chaudhuri, R, Thomson, NC, Brightling, CE, O'Neill, C & Heaney, LG 2015, 'The cost of treating severe refractory asthma in the UK: an economic analysis from the British Thoracic Society Difficult Asthma Registry.', Thorax, vol. 70, no. 4. https://doi.org/10.1136/thoraxjnl-2013-204114

TY - JOUR

T1 - The cost of treating severe refractory asthma in the UK: an economic analysis from the British Thoracic Society Difficult Asthma Registry.

AU - O'Neill, Stephen

AU - Sweeney, Joan

AU - Patterson, Chris C

AU - Menzies-Gow, Andrew

AU - Niven, Rob

AU - Mansur, Adel H

AU - Bucknall, Christine

AU - Chaudhuri, Rekha

AU - Thomson, Neil C

AU - Brightling, Chris E

AU - O'Neill, Ciaran

AU - Heaney, Liam G

N1 - , Wellcome Trust, United Kingdom

PY - 2015/4

Y1 - 2015/4

N2 - Severe refractory asthma poses a substantial burden in terms of healthcare costs but relatively little is known about the factors which drive these costs. This study uses data from the British Thoracic Society Difficult Asthma Registry (n=596) to estimate direct healthcare treatment costs from an National Health Service perspective and examines factors that explain variations in costs. Annual mean treatment costs among severe refractory asthma patients were £2912 (SD £2212) to £4217 (SD £2449). Significant predictors of costs were FEV1% predicted, location of care, maintenance oral corticosteroid treatment and body mass index. Treating individuals with severe refractory asthma presents a substantial cost to the health service.

AB - Severe refractory asthma poses a substantial burden in terms of healthcare costs but relatively little is known about the factors which drive these costs. This study uses data from the British Thoracic Society Difficult Asthma Registry (n=596) to estimate direct healthcare treatment costs from an National Health Service perspective and examines factors that explain variations in costs. Annual mean treatment costs among severe refractory asthma patients were £2912 (SD £2212) to £4217 (SD £2449). Significant predictors of costs were FEV1% predicted, location of care, maintenance oral corticosteroid treatment and body mass index. Treating individuals with severe refractory asthma presents a substantial cost to the health service.

KW - Asthma

KW - Health Economist

U2 - 10.1136/thoraxjnl-2013-204114

DO - 10.1136/thoraxjnl-2013-204114

M3 - Article

C2 - 24917087

SN - 1468-3296

VL - 70

JO - Thorax

JF - Thorax

IS - 4

ER -

The cost of treating severe refractory asthma in the UK: an economic analysis from the British Thoracic Society Difficult Asthma Registry.

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this